IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

EXDENSUR (depemokimab-ulaa) injection

EXDENSUR (depemokimab) is an ultra-long-acting biologic prescription medication used for the add-on maintenance treatment of severe eosinophilic asthma in adults and children aged 12 and older. It helps prevent severe asthma attacks but is not a rescue treatment for sudden breathing problems or acute asthma attacks.  Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name: EXDENSUR
Generic Name: depemokimab-ulaa injection
Strength: Injection:
• 100 mg/mL solution in a single-dose, prefilled pen
• 100 mg/mL solution in a single-dose, prefilled syringe with needle guard
Manufacturer: GlaxoSmithKline
Approved By: EMA, USFDA

Source Details: Patient Information.

EXDENSUR must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access EXDENSUR for asthma on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to EXDENSUR (depemokimab-ulaa) injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

Category:

Contact Info

CORPORATE OFFICE:

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:

M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:

info@indianpharmanetwork.co.in

    Depemokimab, sold under the brand name Exdensur, is a humanized monoclonal antibody used for the treatment of asthma. Depemokimab is an interleukin-5 (IL-5) antagonist monoclonal antibody (humanized immunoglobulin G1 [IgG1] kappa). Depemokimab was developed by GSK. It is structurally similar to mepolizumab but contains seven amino acid substitutions in the heavy chain sequence.
    Depemokimab was approved for medical use in both the United Kingdom and United States in December 2025.

    EXDENSUR (depemokimab-ulaa) injection, for subcutaneous use Initial U.S. Approval: 2025

    Is EXDENSUR (depemokimab-ulaa) available in India?

    EXDENSUR (depemokimab-ulaa) may be accessed in India through a named-patient import process with a valid doctor’s prescription, and Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing and delivery of specialty medicines subject to regulatory approvals.

    How to get EXDENSUR injection delivered in India?

    Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations. Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.

    IPN having representation in Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.

    Who can help source EXDENSUR injection in India legally?

    Named-patient import facilitator contact details
    Company Name: Indian Pharma Network (IPN)
    Address: 60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
    For sourcing and import coordination of specialty medicines, contact:
    Mr. Tarun: +91 9891 296 838
    Mr. Neeraj: +91 9811 747 774
    Email: info@indianpharmanetwork.co.in

    Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.

    Note:
    We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India.

    FAQs

    a

    Steps to get access

    If you possess a prescription issued by a Registered Medical Practitioner (RMP), IPN in Delhi can aid you in acquiring authentic medication globally. Our experts will furnish you with a detailed, step-by-step guidance on the lawful and secure process of importing prescription medicines based on the particulars you provide.

    Step 1. Send a request for your medicine online:-
    Applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).

    Step 2. Verification of documents:-
    We verify your a prescription and necessary documents to import drugs in small quantities for personal use.

    Step 3. Permission to Import:-
    After getting approval of Drugs Controller General (India), we start the process to import of drugs as mentioned in prescription for personal use.

    Step 4. We source your medicine:-
    Our expert sourcing team work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

    Step 5. Delivery of medicine:-
    After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

    Documentation Required

    Doctor’s Prescription –
    We would require prescription from Registered Medical Practitioner (RMP) stating product name, dosage, duration of treatment and diagnosis.

    Patient’s Medical history –
    We would require all test reports and medical reports of the patient for last 3 months.

    Patient’s Identity card –
    We will require scan copy of patient’s identity card and proof of residence to initiate documentation process.

    Why IPN?

    Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. India Pharma Network (IPN), Delhi helps patients, doctors, and hospitals import medicines to India that are not readily available in the domestic market. With over 20 years of experience, IPN provides end-to-end facilitation for accessing specialized, orphan, and life-saving medicines, strictly in compliance with Indian regulations.

    Why Choose India Pharma Network in India?

    • 20+ years of experience in importing specialty medicines in India
    • Expertise in specialty medicines and oncology therapies
    • Nationwide presence with offices in Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.
    • Strict adherence to Named Patient Basis regulations
    • Transparent, patient-focused service

    IPN, Delhi offers extensive representation to patients, doctors, and hospitals across India, including prominent cities such as  Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

    Compliance & Disclaimer

    India Pharma Network acts as a named-patient import facilitator for specialty medicines.

    All imports are:

    • Strictly on a Named Patient Import Basis
    • Exclusively for personal use
    • Not for resale, distribution, or commercial sale
    • Subject to applicable Indian laws and regulatory approvals

    The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions. IPN does not manufacture, sell, or promote medicines and does not provide medical advice.

    Indian Pharma Network (IPN), New Delhi. India

    Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
    Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
    Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

    Indian Pharma Network
    60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

    Mobile / WhatsApp / Phone
    M: +91 9811747774, 9891296838.
    P: +91-11-26532129 / 26536398